Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms [11C]-5-hydroxy-2-(4-methyaminophenyl)benzofuran, [11C]compound 8(University of Nagasaki) |
Target |
Mechanism APP modulators(Beta amyloid A4 protein modulators), PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | JP | 04 Apr 2006 |